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Cord Blood IL-12 Confers Protection 
to Clinical Malaria in Early 
Childhood Life
Yong Song1,2, Ruth Aguilar3,4, Jing Guo1,2, Maria Nelia Manaca3, Augusto Nhabomba3, 
Tamara Katherine Berthoud4, Siew-Kim Khoo5, Selma Wiertsema5, Arnoldo Barbosa3, 
Llorenç Quintó4, Ingrid A Laing5, Alfredo Mayor4, Caterina Guinovart3,4, Pedro L. Alonso3,4, 
Peter N. LeSouëf5, Carlota Dobaño  3,4 & Guicheng (Brad) Zhang1,2,6
Using a well-designed longitudinal cohort, we aimed to identify cytokines that were protective 
against malaria and to explore how they were influenced by genetic and immunological factors. 349 
Mozambican pregnant women and their newborn babies were recruited and followed up for malaria 
outcomes until 24 months of age. Six Th1 cytokines in cord blood were screened for correlation with 
malaria incidence, of which IL-12 was selected for further analyses. We genotyped IL-12 polymorphisms 
in children/mothers and evaluated the genotype-phenotype associations and genetic effects on IL-12 
levels. Maternal IL-12 concentrations were also investigated in relation to Plasmodium infections 
and cord blood IL-12 levels. Our data showed that high background IL-12 levels were prospectively 
associated with a low incidence of clinical malaria, while IL-12 production after parasite stimulation 
had the opposite effect on malaria incidence. IL-12 genotypes (IL-12b rs2288831/rs17860508) and the 
haplotype CGTTAGAG distribution were related to malaria susceptibility and background IL-12 levels. 
Maternal genotypes also exhibited an evident impact on host genotype-phenotype associations. 
Finally, a positive correlation in background IL-12 levels between maternal and cord blood was 
identified. Thus, cord blood background IL-12 concentrations are important for protecting children from 
clinical malaria, likely mediated by both genotypes (children&mothers) and maternal immunity.
Childhood malaria remains one of the leading causes of morbidity and mortality with 500, 000 deaths annu-
ally. According to the WHO World Malaria Report 20171, more than 90% of malaria infections occurred in 
sub-Saharan Africa, of which 90% of deaths were attributable to Plasmodium falciparum. In malaria endemic 
regions, children under five years of age are highly susceptible to clinical malaria, while infants up to six months 
are relatively resistant, although the exact mechanism remains unclarified2. The host response to the parasite 
infection varies from asymptomatic carriage to the classic symptoms of clinical episode (e.g. fever, chills, sweat-
ing, headache and muscle aches), or to even severe life-threatening complications such as severe anaemia, respira-
tory distress, hyperparasitemia and cerebral malaria.
The basic immunity features of Plasmodium infections are pro-inflammatory responses in the early stage 
followed by anti-inflammatory responses during disease progression3,4. Pro-inflammatory Th1-type cytokines 
(IL-1, IL-6, IL-12, IFN-γ and TNF) are thought to be critical for controlling the erythrocytic and hepatic 
stages of Plasmodium infection, but the excessive production of these cytokines might also predispose to 
severe pathology3–5. Anti-inflammatory Th2-type and modulatory cytokines (IL-10 and TGF-β) downregu-
late the Th1-type cytokine response, thereby preventing subjects from severe forms of malaria3,4,6. Numerous 
immuno-epidemiological studies conducted in malaria endemic areas have illustrated the complex and paradox-
ical relationships between inflammatory cytokines and clinical presentations of P. falciparum infection7–13. For 
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example, an elevated expression of IL-1, IL-6, IL-12, IFN-γ and TNF was found in severe malaria and in hyper-
parasitemia, a primary clinical feature of severe disease7–10. On the other hand, other studies showed that reduced 
IL-12 and IFN-γ levels were associated with an increased risk of severe malarial anaemia in children11,12, while 
lower levels of IL-6 were correlated with hyperparasitemia9.
Due to dynamic changes of cytokine profiles during physiopathological processes, most of the published 
studies using cross-sectional designs are not convincing to infer causal relationships of cytokine responses with 
disease phenotypes. A longitudinal birth cohort of infants is therefore important for understanding naturally 
acquired immunity to malaria and the associated genetic regulatory mechanisms14–16.
We hypothesised that Th1 cytokines at birth are important for determining the susceptibility of young chil-
dren to clinical malaria. Using our well-defined prospective cohort14–16, we preliminarily screened six candidate 
Th1 cytokines (IL-1, IL-6, IL-12, IFN-γ, TNF and TNF-β), and identified IL-12 as a promising molecule for 
malaria protection. IL-12 is a heterodimeric p70 protein composed of p35 and p40 subunits encoded by IL-12a 
and IL-12b genes respectively. We further hypothesised that IL-12 polymorphisms are associated with the disease 
protection during early life, through governing the functional expression of IL-12. Here we evaluated the associa-
tions of cord blood IL-12 concentrations, and IL-12 genotypes/haplotypes with malaria outcome. Maternal effects 
on childhood malaria have been reported17,18, thus we also explored the significance of maternal regulation of 
cord blood IL-12 expression in modifying the disease susceptibility in the infant.
Results
Clinical and parasitological characteristics. General information on the children and their mothers 
included in this study is described in our previous publications14–16. Approximately 20% of the children were 
not successfully followed up or subjected to laboratory tests due to a variety of reasons such as parental with-
drawal and insufficient blood collection. During the two-year follow-up, 108 children (108/326, 33.1%) had one 
or more malaria episodes. Twenty-three children (23/284, 8.1%) were diagnosed with anaemia at the endpoint of 
follow-up. Concurrently, 32 (32/284, 11.3%) and 101(101/256, 39.5%) children were identified as P. falciparum 
positive for parasitemia by microscopic method and qPCR assay, respectively. In terms of pregnancy infection, we 
found 27 (27/349, 7.7%) mothers presented with maternal parasitemia and 60 (60/277, 21.7%) mothers with pla-
cental infection, determined by microscopy and histology, respectively. Additionally 25 (25/254, 7.2%) newborns 
presented congenital infection, as detected by qPCR in filter papers, which was included as one of the confound-
ing factors for adjustment in our analysis models.
Cord cytokine and malaria phenotypes. Using Poisson regression analysis and taking into account the 
effects of the confounding factors e.g. intervention, mother’s age, use of insecticide-treated mosquito nets (ITNs), 
use of indoor residual spraying (IRS) and congenital infection (parasites in cord), we investigated the association 
between the concentration of six Th1 cytokines secreted by cord blood cells in culture supernatants and the inci-
dence of clinical malaria in the second year of life in young children (Table 1). We found that the background and 
stimulated/specific IL-12 levels had an opposite association with disease onset (Table 1). A high background IL-12 
level in cord blood was prospectively associated with a low incidence of clinical malaria (p = 0.020) (Table 1). In 
contrast, a high IL-12 production or a high specific IL-12 response after P. falciparum antigen stimulation was 
significantly related to an increased risk of clinical malaria (p < 0.001) (Table 1). The stimulated form of IFN-γ 
also demonstrated a positive association with high morbidity of childhood malaria (p = 0.010) (Table 1).
Further, we tested the association of cord cytokine levels with other malaria related phenotypes including par-
asitemia and anaemia. The specific IL-12 response was marginally higher in 2 year old children who had micro-
scopically confirmed parasitemia (p = 0.054), relative to those without parasitemia (Supplementary Figure 1a). 
After controlling the aforementioned confounders, the difference showed statistical significance (p = 0.044) 
(Supplementary Table 1). As for anaemia, the background IL-1 levels were significantly lower in children with 
anaemia (p = 0.024) (Supplementary Table 1), whereas such difference was not evident for IL-12 (Supplementary 
Figure 1b). Using the Pearson correlation analysis, we found that the Plasmodium-specific IL-12 response was 
positively associated with blood P. falciparum copy number (r = 0.150, p = 0.036, n = 196) quantified by qPCR 
assay in filter paper samples. The specific IL-12 response was not correlated with plasma haemoglobin concen-
tration. Moreover, a correlation between IL-1 levels and plasma haemoglobin concentration was not detected.
Apart from the associations outlined above, we did not observe any other significant differences 
(Supplementary Table 1). As IL-12 proved promising in preventing childhood malaria, our subsequent studies 
were focused on this cytokine, while the other cytokines were thereafter excluded from further analysis.
Genotypes and haplotypes with malaria phenotypes. The distributions of the genotypes in young 
children and their mothers are summarized in Supplementary Table 2. Significant departure from the HWE was 
observed for children’s IL-12b rs2288831 (p = 0.025) and mothers’ IL-12b rs2546890 (p = 0.010) in the distribu-
tion of genotypes in the overall population. However, when we tested in the respective control groups (children 
without congenital infection and mothers without maternal parasitemia), such deviation was not significant for 
any of the examined single nucleotide polymorphisms (SNPs) in both children and mothers (p > 0.05).
Out of the four IL-12 SNPs examined, the IL-12b rs2288831 and rs17860508 genotypes were found to be 
significantly associated with malaria incidence (p = 0.005 and p = 0.007 respectively) (Table 2). Children with 
allele C of IL-12b rs2288831 had a significantly lower incidence of malaria in the second year than those with 
allele T (CC vs CT, p = 0.003; CC vs TT, p = 0.001) (Fig. 1a). The GC allele of host IL-12b rs17860508 was asso-
ciated with a high risk of clinical malaria occurrence compared to the TTAGAG allele (TTAGAG vs TTAGAG/
GC, p = 0.004; TTAGAG vs GC, p = 0.002) (Fig. 1b). Similar effects were revealed for the maternal genotypes of 
IL-12b rs2288831 and rs17860508 and their association with clinical episodes of malaria (p < 0.001 and p = 0.005 
respectively) (Table 2 and Fig. 1). Additionally a significant effect of the genotype distribution of maternal IL-12b 
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rs2546890 on malaria incidence was identified (p = 0.008), with increasing risk from allele G to A (Table 2). After 
adjusting for the corresponding maternal SNPs, the effect of children’s IL-12b rs17860508 genotypes on malaria 
was decreased but remained significant (p = 0.023), while the significant effect of IL-12b rs2288831 disappeared 
(p = 0.929).
A strong linkage was identified amongst IL-12b gene SNP rs2546890, rs2288831 and rs17860508 
(Supplementary Figure 2), and the association of haplotypes with malaria episodes was subsequently investi-
gated (Table 2). The host CGTTAGAG haplotype was significantly related to a decreased risk of malaria episodes 
during the first 2 years of life (High probability vs Low probability, p = 0.025; High probability vs Null, p = 0.013) 
(Fig. 2a), while newborns with a TGGC haplotype had an increased risk of malaria episodes (High probability vs 
Null, p = 0.006) (Fig. 2a). The haplotype TAGC did not alter the susceptibility to a clinical malaria episode.
Nevertheless, analysing genetic effects of IL-12 on parasitemia and anaemia, we did not observe significant 
associations of either IL-12 genotype or haplotypes with these malaria related phenotypes (Supplementary 
Table 3).
Correlation of IL-12 genotypes/haplotypes with IL-12 concentrations. IL-12 levels were signif-
icantly different in the genotypes of IL-12b rs2288831 (p = 0.030) and rs17860508 (p = 0.036) (Supplementary 
Table 4). Specifically, the background IL-12 concentrations were lower in children with heterozygous CT for 
IL-12b rs2288831 than those with homozygous CC (p = 0.078) and TT (p = 0.012) (Fig. 3a). Likewise, children 
with TTAGAG or GC genotype had significantly or marginally higher levels of background IL-12 than those 
with heterozygous TTAGAG/GC, respectively (Fig. 3b). Apart from this, we did not observe any other significant 
effects of host genotype on IL-12 levels.
The host CGTTAGAG haplotype had a significant effect on background IL-12 production (p = 0.018) 
(Supplementary Table 4). Low probability of CGTTAGAG haplotype was related to low background IL-12 levels 
and an increased risk of malaria episodes as outlined earlier (Fig. 2), consistent with the effects of the cord blood 
IL-12 levels on malaria outcome (Table 1).
Impact of maternal immunity on cord blood IL-12 levels. The background levels of IL-12 in cord 
blood mononuclear cells were positively correlated with those in maternal peripheral blood mononuclear cells 
(PBMC) (r = 0.343, p < 0.001). However, there was no significant correlation between cord and maternal specific 
IL-12 production in response to antigen stimulation (r = 0.014, p = 0.845). Further analysis was performed to 
evaluate the impact of maternal malaria and congenital malaria on maternal and cord blood background IL-12 
levels (Fig. 4). The background IL-12 concentrations in maternal peripheral blood were decreased in response to 
maternal parasitemia, although such change did not reach statistical significance (p = 0.060) (Fig. 4a). However, 
neither maternal nor cord blood background IL-12 levels differed in women with/without placental infection 
(Fig. 4b) or in newborns with/without congenital malaria (Fig. 4c)
Cytokine IRRs
95% CI
pLower Upper
IL-1
Background 0.93 0.82 0.94 0.321
Stimulated 0.96 0.83 1.11 0.564
Specific 1.11 0.87 1.42 0.407
IL-6
Background 0.98 0.88 1.09 0.666
Stimulated 0.97 0.86 1.08 0.517
Specific 0.96 0.76 1.20 0.693
IL-12
Background 0.74 0.57 0.96 0.020
Stimulated 1.61 1.24 2.09 <0.001
Specific 1.46 1.23 1.73 <0.001
IFN-γ
Background 0.97 0.77 1.23 0.819
Stimulated 1.48 1.10 1.99 0.010
Specific 1.16 0.96 1.40 0.136
TNF
Background 0.91 0.78 1.06 0.207
Stimulated 0.91 0.78 1.06 0.214
Specific 1.01 0.80 1.27 0.957
TNF-β
Background 0.71 0.37 1.35 0.298
Stimulated 1.04 0.71 1.52 0.847
Specific 1.53 0.94 2.50 0.090
Table 1. Association of pro-inflammatory cytokines secreted by cord blood with the incidence of clinical 
malaria in the second year of life. Poisson regression model was employed after adjusting for intervention, 
mother’s age, parity, infant sex, use of insecticide-treated mosquito nets, use of indoor residual spraying, 
and congenital infection. 95% CI: 95% confidence interval. Background: cytokine levels without stimulation 
(uninfected erythrocytes); Stimulated: cytokine production after P. falciparum schizont lysate stimulation; 
Specific: level of cytokine after stimulation divided by its background level. n = 240 for each group. IRR: 
Incidence rate ratio.
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Discussion
Our study showed that children with a high background IL-12 expression in cord blood were highly resistant to 
the development of malaria episodes. We further established the relationships between host IL-12 polymorphisms 
and incidence of childhood malaria, which was dependent on maternal genotypes. IL-12 genotypes (IL-12b 
rs2288831 and rs17860508) and the haplotype CGTTAGAG distribution were related to the background IL-12 
levels. In addition, we showed that the cord blood IL-12 levels were associated with the maternal IL-12 levels, 
which were affected by maternal malaria. Thus, we conclude that the background IL-12 levels in cord blood may 
be important for protecting young children from Plasmodium infection, likely mediated by the genotypes of chil-
dren and mothers as well as maternal immunity.
Out of six Th1 pro-inflammatory cytokines investigated, we identified significant associations of IL-12 and 
IFN-γ at birth with the incidence of malaria infection in the first 2 years of life. Data from animal models of 
malaria indicated that an early response of both cytokines was essential for parasite clearance, but had to be main-
tained on a delicate balance to avoid inappropriate induction leading to malaria pathology4. Indeed, in the present 
study the relationship between these cytokines and disease phenotypes appears to be complex, particularly for 
IL-12. Specifically, we found that the background IL-12 levels were associated with protection of malaria onset, 
while Plasmodium-specific IL-12 production was associated with a high risk of malaria episodes, parasitemia and 
anaemia. However, given the double-edged effects of these cytokines, the contradictory associations are not so 
unexpected and are consistent with the previous reports19,20. Dodoo et al. demonstrated that the propensity of a 
person to secrete IL-12, IFN-γ, and TNF was associated with protection against parasitemia, clinical malaria, and 
anaemia19. On the contrary, the secretory IL-12 induced by the mitogen phytohemagglutinin or Mycobacterium 
tuberculosis antigen was negatively correlated to haemoglobin concentration19. Similarly, Riley et al. showed that 
IFN-γ production from PBMC in response to soluble exoantigens of P. falciparum was associated with increased 
risk of malaria symptoms20, supporting our findings that antigen-induced IFN-γ is a risk factor for increasing 
malaria susceptibility. Nevertheless, innate IFN-γ response to malaria antigens was reported to be stronger for live 
than for dead parasites and both γδ T cells and NK cells responded preferentially to live parasites21. These results 
raise the possibility that a protective IFN-γ response may derive from rapidly activated cell types rather than from 
memory T cells19. Thus, one of the limitations in the present study is that we investigated the cytokine production 
responding to schizont lysate, which may be different from live parasites19. However, an in vivo mouse study 
confirmed that infection with blood-stage lethal P. berghei NK65 induced IL-12 production, which was critically 
involved in the pathogenesis of liver injury via increasing IFN-γ22. Treatment of these infected mice with neutral-
izing monoclonal antibodies against IL-12 prolonged the survival and diminished liver injury22. Taken together, 
although further studies are required to ascertain the role of IL-12 production in response to the parasite infec-
tion, our data clearly demonstrated the importance of basal IL-12 levels in protecting children from Plasmodium 
n IRRs
95%
pLower Upper
Host genotypes
   IL-12a rs568408
294 0.91 0.72 1.15 0.428
   (0: GG; 1: GA; 2: AA)
   IL-12b rs2288831
289 0.74 0.6 0.92 0.005
   (0: TT; 1: TC; 2: CC)
   IL-12b rs17860508
294 0.73 0.58 0.92 0.007
   (0: GC; 1: GC/TTAGAG; 2: TTAGAG)
   IL-12b rs2546890
292 0.75 0.79 1.19 0.782
   (0: GG; 1: GA; 2: AA)
Host haplotypes
   CGTTAGAG 281 0.58 0.36 0.95 0.031
   TAGC 281 0.96 0.62 1.49 0.849
   TGGC 281 1.86 1.25 2.78 0.002
Maternal genotypes
   IL-12a rs568408
299 0.78 0.6 1.01 0.059
   (0: GG; 1: GA; 2: AA)
   IL-12b rs2288831
288 0.61 0.47 0.78 <0.001
   (0: TT; 1: TC; 2: CC)
   IL-12b rs17860508
296 0.7 0.54 0.9 0.005
   (0: GC; 1: GC/TTAGAG; 2: TTAGAG)
   IL-12b rs2546890
292 1.37 1.08 1.73 0.008
   (0: GG; 1: GA; 2: AA)
Table 2. Association of IL-12 genotypes/haplotypes with the incidence of clinical malaria in the second year 
of life. Poisson regression model was employed after adjusting for intervention, mother’s age, parity, infant sex, 
use of insecticide-treated mosquito nets, use of indoor residual spraying, congenital infection. 95% CI: 95% 
confidence interval. IRR: Incidence rate ratio.
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infection. This finding has significant implications with respect to vaccine design strategy, e.g. up-regulating IL-12 
expression in cells rather than directly supplying exogenous IL-12 to increase cellular resistance to infection.
The variation of cytokine production may be related to individual genetic differences19, affecting the outcome 
of Plasmodium infection. A functional promoter variant (rs17860508) in IL-12b, was found to have a dominant 
effect on cerebral malaria susceptibility in Tanzanian23 and Malian children24, and Thai population25, but not in 
Kenyan23 and Burkina Faso subjects26. In our cohort study, we found that heterozygous alleles of both IL-12b 
rs2288831 and rs17860508 were related to reduced expression of cord blood background IL-12 levels and a high 
risk of malaria episodes. These observations suggest that IL-12b polymorphisms, via regulation of baseline IL-12 
production, influence the outcome of malaria infection. Nevertheless, our data showed that homozygous GC of 
IL-12b rs17860508 was associated with increased morbidity in 2-year-old Mozambican children, while others 
demonstrated that homozygosity for the CTCTAA allele affected susceptibility to cerebral malaria24,25. The appar-
ent discrepancy may be explained by the different disease phenotypes observed (clinical episodes in the present 
study vs severe malaria in other studies23–25), particularly considering the different roles of cytokines in malaria 
progression, or due to the different ethnic groups studied.
Both homozygous alleles of TT and GC in IL-12b rs2288831 and rs17860508 were related to increased inci-
dence of developing clinical malaria, compared to the homozygous alleles of CC and TTAGAG respectively. 
However, IL-12 levels were comparable between the two groups of homozygosity. We speculated that genetic 
variants were likely to form a regulatory haplotype to affect the function expression. As expected, construction 
of haplotypes for the three polymorphisms (IL-12b variants rs2546890, rs2288831 and rs17860508) revealed that 
carriage of the CGTTAGAG haplotype was associated with a reduced incidence of malaria episodes, while high 
probability of transmitting the TGGC haplotype was associated with increased susceptibility to the outcome of 
Plasmodium infection. Moreover, basal IL-12 concentrations were higher in children with the CGTTAGAG hap-
lotype, confirming our hypothesis that the IL-12b haplotype exhibits a cis-regulatory effect on IL-12 expression, 
contributing to disease protection. However, the distribution of the TGGC haplotype was not related to the cord 
blood IL-12 levels, and thereby the protective mechanism could not be explained by modulating IL-12 expression. 
Additional mechanisms (e.g. epistatic effects) may exist, as evidenced by genetic interactions of IL-12 with IL-
1027,28, haemoglobin C (Hbc)29 and toll-like receptor 4 (TLR4)30 in mediating IL-12 production or altering malaria 
related phenotypes.
Figure 1. IL-12b Genotypes and Malaria Incidence: Incidence rate ratios were compared in host and maternal 
genotypes of IL-12b rs2288831 (a) and IL-12b rs17860508 (b). The homozygous genotypes CC and TTAGAG 
were used as reference allele for the two IL-12b polymorphisms respectively. Poisson regression analysis was 
used, controlling for intervention, mother’s age, parity, infant sex, use of insecticide-treated mosquito nets, use 
of indoor residual spraying, congenital infection. Values represent Mean (95% confidence interval).
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Similar to the children’s genotypes, association of mothers’ genotypes with clinical malaria showed a similar 
pattern and consistent direction. Moreover, the impact of children’s genotypes on malaria episodes was attenu-
ated markedly or disappeared, after adjusting for the corresponding maternal genotypes, suggesting a maternal 
genotype-dependent mechanism underlying host genotype-phenotype interactions. In addition, prenatal expo-
sure to malaria is well documented to increase parasite density and severe malaria risk in offspring. Our data 
showed a positive correlation of background IL-12 levels between maternal and cord blood. Moreover, maternal 
malaria seemed to decrease the background IL-12 concentrations in the mother. As such, cord blood IL-12 levels 
may play a key role in transducing malaria signalling to modify infant susceptibility. It is speculated that owing 
to the passively acquired malarial antigens from maternal source, the fetal cell is primed and activated to produce 
the coordinative expression of Th1/Th2 phenotypes in fetal blood31.
In conclusion, we report for the first time that basal expression of IL-12 in cord blood cells confers protection 
from Plasmodium infection throughout early life. IL-12 genotype/haplotypes alter paediatric malaria suscepti-
bility, which is in part associated with regulating IL-12 expression. Finally, we found that maternal genotype and 
IL-12 response were associated with the cord blood IL-12 levels and subsequent development of malaria disease 
in the offspring. It follows that interactions between maternal genetic factors and environment determine child-
hood malaria outcome, through altering the inherent expression of the cord blood IL-12.
Materials and methods
Participants. This study was part of the AgeMal project (ClinicalTrials.gov identifier NCT00231452) 
described previously15. The primary aim of this study was to investigate the effect of age of first exposure to 
malaria on the development of naturally acquired immunity in infants. In summary, the study was a three-arm 
randomized, double-blind, placebo-controlled trial carried out in a malaria endemic area (Manhiça district of 
Southern Mozambique) from August 2005 to July 2009. A total of 349 HIV-negative pregnant women and their 
newborn babies were recruited and followed up until two years of life after birth. The first exposure to P. falci-
parum was selectively controlled at varying postnatal stages (2 to 5 months, early exposure; 5 to 10 months, late 
exposure; or none, control) with monthly chemoprophylaxis with sulfadoxine-pyrimethamine and artesunate. 
However, such strategy did not affect outcomes of P. falciparum infection and antibody response14,15. Written 
informed consent was obtained from all mothers. The study was approved by the National Mozambican Ethics 
Figure 2. Children IL-12b Haplotypes and Malaria Incidence/Cord Blood IL-12 Production: Incidence rate 
ratios were compared in children with different probabilities of carrying the haplotypes CGTTAGAG and 
TGGC using Poisson regression model, with high probability as reference haplotype (a). The cord blood 
background IL-12 levels were stratified by different probabilities of carrying host haplotypes CGTTAGAG and 
TGGC using linear regression model (b). All analyses are adjusted for the confounding factors. High: 100% 
probability; Low: 20–50% probability; Null: zero probability. Values represent Mean (95% confidence interval).
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Review Committee, the Hospital Clinic of Barcelona Ethics Review Committee, and the Princess Margaret 
Hospital for Children Ethics Committee (1473/EP) in Perth. All experiments were performed in accordance with 
relevant guidelines and regulations of the Hospital Clinic of Barcelona and the School of Paediatrics and Child 
Health, the University of Western Australia.
Cytokine measurement. Blood mononuclear cells were isolated from maternal and cord bloods using a 
lymphoprep gradient, and resuspended in complete RPMI medium. The fresh cells were stimulated with unin-
fected erythrocytes or P. falciparum schizont extract32. After 24 h culture, IL-1, IL-6, IL-12 (p70 heterodimer), 
IFN-γ, TNF and TNF-β levels were measured in the culture supernatants using the Bender MedSystems Human 
Th1/Th2 11plex FlowCytomix multiplex kit and analyzed on a FACS Canto II (Becton Dickinson, Franklin Lakes, 
NJ, USA)32,33. Cytokine concentrations (pg/ml) measured in this way represented background cytokines with-
out stimulation (uninfected erythrocytes), or cytokine production in response to P. falciparum-specific stim-
ulation. The secretory capacity of cytokines was further expressed by division of background cytokines from 
the corresponding stimulated cytokines (stimulated cytokine/background cytokine), defined as specific cytokine 
responses after malaria antigen stimulation.
Disease phenotypic definitions. As described previously15, newborns were followed up weekly (from 
birth to 10.5 months) or monthly (from 10.5 to 24 months) for malaria case detection and in case of illness, 
subjected to clinical assessments and blood smear. The case detection included taking axillary temperatures and 
recording any history of fever. A clinical malaria episode was defined as axillary temperature ≥37.5 °C, or a his-
tory of fever within the prior 24 h plus the presence of P. falciparum of any density diagnosed by microscopy. Since 
the interventions were conducted in the first year of life, a clinical episode of malaria infection during the second 
year of life was the main phenotype in our analysis. Two other phenotypes, namely anaemia and parasitemia, 
were also assessed at 24 months of age. Anaemia was defined as haemoglobin <8 g/dl. For childhood parasitemia 
except assessed by microscopy, qPCR was also used to determine cord blood or peripheral blood P. falciparum 
copy number in filter paper samples at birth and 24 months of age. Concerning maternal malaria, maternal para-
sitemia was determined in peripheral blood by microscopy and placental infection was assessed by histology. The 
laboratory test details were described in our recent paper32.
Figure 3. Cord Blood IL-12 Levels and Children IL-12b Polymorphisms: The cord blood background IL-12 
levels and specific IL-12 production after P. falciparum schizont extract stimulation were stratified by children 
IL-12b genotypes of rs2288831 (a) and rs17860508 (b) using linear regression analysis with adjustment of the 
confounding effects. Values are Mean (SD).
www.nature.com/scientificreports/
8SCIenTIfIC RepoRts |  (2018) 8:10860  | DOI:10.1038/s41598-018-29179-y
Genotyping. Genomic DNA from PBMC was purified using an automated DNA extraction instrument 
(Autopure LS; Qiagen, Hilden, Germany). We selected one SNP rs568408 in IL-12a gene 3′-UTR and three SNPS 
(IL-12b rs17860508, rs2546890, rs2288831) in IL-12b gene regions. Among these polymorphic markers, IL-12a 
rs568408, IL-12b rs17860508 and IL-12b rs2546890 were found to be related to malaria infections24,25, while 
IL-12b rs2288831 was shown to have a strong linkage disequilibrium with IL-12b rs1786050826. The four SNPs 
Figure 4. Maternal/Cord Blood IL-12 Production and Prenatal Malaria Infection: The background IL-12 levels 
in maternal peripheral blood and cord blood were compared in positive/negative maternal parasitemia (a), 
positive/negative placental infection (b) and positive/negative cord blood infection (c). Differences between the 
two groups are compared using independent t test. Values are Mean (SD).
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were genotyped by using the iPLEX assay on a MALDI-TOF MassARRAY platform (Sequenom, San Diego, CA, 
USA) in the Australian Genome Research Facility.
Data analysis. The allele and genotype distribution was examined for the Hardy Weinberg Equilibrium 
(https://regepi.bwh.harvard.edu/IIPGA2/Bioinformatics/) and compared using chi square test. Linkage disequi-
librium analysis was performed using Haploview v4.2 software.
Log-transformation was used to normalize the distribution of cytokine values. The associations between 
cytokine concentrations and disease phenotypes (e.g. anaemia, parasitemia or prenatal malaria) or genotypes/
haplotypes were analysed using independent sample t test or one-way ANOVA, respectively. Linear regression 
was used to verify the associations in children after adjusting for the potential confounders e.g. mother’s age, 
parity, infant sex, ITNs, IRS, and congenital infection since these factors were known to influence cord cytokine 
profile and childhood malaria susceptibility17,18,34,35. The variable of intervention group (early, late exposure and 
control) was fitted in the regression model as an additional adjustment for analysing cytokine association with 
the malaria disease phenotypes. Poisson regression was used to determine the risk of the incidence of clinical 
malaria in the second year of life and its association with cytokine production and genotypes/haplotypes of IL-
12 with adjustment for the confounding factors outlined above. The Pearson correlation index was calculated to 
determine the association among different continuous variables using linear regression analysis.
SPSS (version 20.0: SPSS Inc., Chicago, IL, USA) was used for the statistical analyses. Data were presented as 
mean (95% CI or SD). Differences were accepted as significant at p < 0.05.
Data availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding authors on reasonable request.
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